Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

GLPG

Galapagos (GLPG)

Galapagos

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:EU:GLPG

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next >>

Date	Time	Source	Headline	Symbol	Company
05/25/2022	4:01PM	GlobeNewswire Inc.	Galapagos to showcase commitment to rheumatoid arthritis care at the upcoming European League Against Rheumatism congress	EU:GLPG	Galapagos
05/25/2022	4:01PM	GlobeNewswire Inc.	Galapagos to showcase commitment to rheumatoid arthritis care at the upcoming European League Against Rheumatism congress	EU:GLPG	Galapagos
05/06/2022	4:01PM	GlobeNewswire Inc.	Galapagos creates new subscription right plans	EU:GLPG	Galapagos
05/06/2022	4:01PM	GlobeNewswire Inc.	Galapagos creates new subscription right plans	EU:GLPG	Galapagos
05/05/2022	4:01PM	GlobeNewswire Inc.	Galapagos demonstrates regulatory and commercial progress in Q1 2022	EU:GLPG	Galapagos
05/05/2022	4:01PM	GlobeNewswire Inc.	Galapagos demonstrates regulatory and commercial progress in Q1 2022	EU:GLPG	Galapagos
04/26/2022	4:01PM	GlobeNewswire Inc.	Galapagos announces appointment of Dr. Paul Stoffels as Chairman of the board	EU:GLPG	Galapagos
04/26/2022	4:01PM	GlobeNewswire Inc.	Galapagos announces appointment of Dr. Paul Stoffels as Chairman of the board	EU:GLPG	Galapagos
03/28/2022	2:01AM	GlobeNewswire Inc.	Jyseleca® approved in Japan for ulcerative colitis	EU:GLPG	Galapagos
03/28/2022	2:01AM	GlobeNewswire Inc.	Jyseleca® approved in Japan for ulcerative colitis	EU:GLPG	Galapagos
03/24/2022	4:17PM	GlobeNewswire Inc.	Correction: Galapagos publishes 2021 annual report and announces extraordinary and annual shareholders’ meetings	EU:GLPG	Galapagos
03/24/2022	4:17PM	GlobeNewswire Inc.	Correction: Galapagos publishes 2021 annual report and announces extraordinary and annual shareholders’ meetings	EU:GLPG	Galapagos
03/24/2022	4:01PM	GlobeNewswire Inc.	Galapagos publishes 2021 annual report and announces extraordinary and annual shareholders’ meetings	EU:GLPG	Galapagos
03/24/2022	4:01PM	GlobeNewswire Inc.	Galapagos publishes 2021 annual report and announces extraordinary and annual shareholders’ meetings	EU:GLPG	Galapagos
03/18/2022	5:01PM	GlobeNewswire Inc.	Galapagos increases share capital through subscription right exercises	EU:GLPG	Galapagos
03/18/2022	5:01PM	GlobeNewswire Inc.	Galapagos increases share capital through subscription right exercises	EU:GLPG	Galapagos
02/24/2022	4:01PM	GlobeNewswire Inc.	Galapagos 2021 results set stage for future growth	EU:GLPG	Galapagos
02/24/2022	4:01PM	GlobeNewswire Inc.	Galapagos 2021 results set stage for future growth	EU:GLPG	Galapagos
02/03/2022	4:01PM	GlobeNewswire Inc.	Galapagos receives transparency notification from EcoR1 Capital	EU:GLPG	Galapagos
02/03/2022	4:01PM	GlobeNewswire Inc.	Galapagos receives transparency notification from EcoR1 Capital	EU:GLPG	Galapagos
02/02/2022	4:01PM	GlobeNewswire Inc.	Galapagos provides further insights into the treatment of ulcerative colitis at the European Crohn’s and Colitis Organization (ECCO) annual congress	EU:GLPG	Galapagos
02/02/2022	4:01PM	GlobeNewswire Inc.	Galapagos provides further insights into the treatment of ulcerative colitis at the European Crohn’s and Colitis Organization (ECCO) annual congress	EU:GLPG	Galapagos
01/26/2022	4:40PM	GlobeNewswire Inc.	Galapagos creates new subscription right plan	EU:GLPG	Galapagos
01/26/2022	4:40PM	GlobeNewswire Inc.	Galapagos creates new subscription right plan	EU:GLPG	Galapagos
01/26/2022	4:01PM	GlobeNewswire Inc.	Galapagos appoints Paul Stoffels as Chief Executive Officer	EU:GLPG	Galapagos
01/26/2022	4:01PM	GlobeNewswire Inc.	Galapagos appoints Paul Stoffels as Chief Executive Officer	EU:GLPG	Galapagos
01/18/2022	4:01PM	GlobeNewswire Inc.	JYSELECA®▼ (FILGOTINIB) LICENSED FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN GREAT BRITAIN	EU:GLPG	Galapagos
01/18/2022	4:01PM	GlobeNewswire Inc.	JYSELECA®▼ (FILGOTINIB) LICENSED FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN GREAT BRITAIN	EU:GLPG	Galapagos
01/13/2022	4:01PM	GlobeNewswire Inc.	Galapagos creates new subscription right plan	EU:GLPG	Galapagos
01/13/2022	4:01PM	GlobeNewswire Inc.	Galapagos creates new subscription right plan	EU:GLPG	Galapagos

Showing the most relevant articles for your search:EU:GLPG

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next >>

Canopus Biopharma (PK)

Gold and GemStone Mining (PK)

Marketing Worldwide (PK)

Virexit Technologies (PK)

Bell Buckle (PK)

Brookmount Explorations (PK)

NioCorp Developments

Anavex Life Sciences

Ubiquitech Software (PK)

Fannie Mae (QB)

Decentral Life (PK)

Seven Arts Entertainment (PK)

Delayed Upgrade Clock